As part of our monthly news service we would like to make you aware of the CML publications of the month. From the many papers published every month Professor Jerry Hughes has selected topical, interesting papers for your perusal that also include interesting articles from the emerging economic regions and publications on COVID-19 and CML.

Read Professor Hughes' CML publications of the month: December 2020

Clinical publications

• How to manage CML patients with comorbidities
  Cortes J. Blood, November 2020 – open access publication
  

• Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia
  Abaza Y et al. Am J Hematol, November 2020

• Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: Updates from the LAST study on patient-reported outcomes and biomarkers for relapse
  Braun TP and Druker BJ. JAMA Oncol, November 2020

• BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analysed by NGS
  Soverini S et al. Leukemia, December 2020 (epub ahead of print)

• First-generation vs second-generation tyrosine kinase inhibitors: which is best at diagnosis of chronic-phase chronic myeloid leukemia
  Oehler VG. Hematology Am Soc Hematol Educ Program, December 2020 – open access publication
  

• Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice
  Breccia M et al. Expert Rev Hematol, December 2020

• Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI-PIO) in chronic myeloid leukemia with deep molecular response
  Pagnano KBB et al. Am J Hematol, December 2020 – open access publication

ERSAP publications

• Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study
  Ning L et al. Exp Hematol Oncol, November 2020 – open access publication

COVID-19 publications

• The management of hematologic malignancies during the COVID-19 pandemic
  Hus I et al. Expert Opin Pharmacother, December 2020 (epub ahead of print) - open access publication
  
  
• Outcomes of patients with haematological malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
  Wood WA et al. Blood Adv, December 2020 – open access publication